January 6, 2022
The Ministry of Health, Labor and Welfare (MHLW) has updated its COVID-19 care guide, adding MSD’s oral antiviral Lagevrio (molnupiravir) and GlaxoSmithKline’s antibody medicine Xevudy (sotrovimab) to the approved drug list. For Lagevrio, the MHLW called for its administration promptly...read more